Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
Oligodendrocytes
CRISPRi
Myotonic Dystrophy
Oligodendrocyte
Transgenic mouse model
Glutamate
Gene Therapy
MBNL
PCR
Humans
Glial cells
Endurance training
RNA biology
Cell penetrating peptide
Dynamin 2
DMPK
ARN
Centronuclear myopathy
Dystrophin
Knockout
Cardiac muscle
RNA interference
Cell culture model
Trinucleotide repeat expansion
Heart
Motoneuron
Trinucleotide Repeat Expansion
GABA
Antisense oligonucleotide
Desmin
Myotonic Dystrophy Type 1
Aging
Astrocytes
Mouse model
Myotonic dystrophy mouse models
Genotype phenotype correlation
CTG repeat contractions
CTG repeats
Intermediate filament
Animals
Myotonic Dystrophy type 1
Brain dysfunction
CMS
Dilated cardiomyopathy
Myostatin
Exercise
Alternative splicing
Exercice
Quantitative microdialysis
Cytoskeleton
DMSXL mice
Cell model
Hypoxia
Heart failure
Gene editing
Autophagy
Glucocorticoid-receptor
Therapy
CONGENITAL MYATHENIC SYNDROME
Expression
Antisense oligonucleotides
DM1
Mice
Muscular dystrophy
RNA splicing
Muscle
AAV
PacBio
BIOLOGIE MOLECULAIRE
Male
Skeletal muscle
Mouse models
Transcriptomics
Brain
In vivo
Thérapie génique
Myotonic dystrophy
Long read sequencing
GSK3
Acetylcholinesterase knockout mouse
Dystrophie myotonique
Neuron
CTG repeat instability
Maximal force
Duchenne muscular dystrophy
Gene therapy
Diaphragm
Dystrophie Myotonique
Fibrosis
Acetylcholinesterase deficiency
Central nervous system
KNOCKOUT MICE
Myelin
Acute coronary syndrome
CRISPR/Cas9
ACETYLCHOLINESTERASE
Myotonic dystrophy type 1
Transgenic mouse
Astrocyte
Glucocorticoids